Two Sigma Investments, LP Harvard Bioscience Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 33,706 shares of HBIO stock, worth $73,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,706

Previous 59,224 43.09%

Holding current value

$73,142

Previous $168,000 46.43%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.64 - $3.54 $67,367 - $90,333	-25,518 Reduced 43.09%	33,706 $90,000
Q2 2024 Aug 14, 2024	BUY	$2.77 - $4.63 $47,763 - $79,835	17,243 Added 41.07%	59,224 $168,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $45,257 - $60,680	-11,258 Reduced 21.15%	41,981 $177,000
Q4 2023 Feb 14, 2024	SELL	$4.0 - $5.49 $311,128 - $427,023	-77,782 Reduced 59.37%	53,239 $284,000
Q3 2023 Nov 14, 2023	BUY	$4.0 - $5.82 $43,588 - $63,420	10,897 Added 9.07%	131,021 $563,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $215,944 - $317,474	51,538 Added 75.14%	120,124 $659,000
Q1 2023 May 15, 2023	SELL	$2.45 - $4.22 $150,077 - $258,500	-61,256 Reduced 47.18%	68,586 $288,000
Q4 2022 Feb 14, 2023	SELL	$2.12 - $2.86 $91,745 - $123,769	-43,276 Reduced 25.0%	129,842 $359,000
Q3 2022 Nov 14, 2022	BUY	$2.33 - $3.92 $171,476 - $288,492	73,595 Added 73.95%	173,118 $443,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $153,618 - $300,680	46,835 Added 88.89%	99,523 $358,000
Q1 2022 May 16, 2022	SELL	$5.16 - $7.14 $435,364 - $602,423	-84,373 Reduced 61.56%	52,688 $327,000
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $503,758 - $646,898	-79,083 Reduced 36.59%	137,061 $966,000
Q3 2021 Nov 15, 2021	SELL	$6.98 - $8.47 $306,701 - $372,171	-43,940 Reduced 16.89%	216,144 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$5.44 - $8.4 $659,137 - $1.02 Million	121,165 Added 87.22%	260,084 $2.17 Million
Q1 2021 May 17, 2021	BUY	$3.91 - $6.99 $152,239 - $272,162	38,936 Added 38.94%	138,919 $758,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $4.5 $134,907 - $202,360	44,969 Added 81.74%	99,983 $429,000
Q3 2020 Nov 16, 2020	BUY	$2.75 - $4.2 $11,275 - $17,220	4,100 Added 8.05%	55,014 $166,000
Q2 2020 Aug 14, 2020	SELL	$2.12 - $3.14 $40,706 - $60,291	-19,201 Reduced 27.39%	50,914 $158,000
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $143,408 - $332,263	-100,992 Reduced 59.02%	70,115 $155,000
Q4 2019 Feb 14, 2020	SELL	$2.45 - $3.25 $237,598 - $315,181	-96,979 Reduced 36.17%	171,107 $522,000
Q3 2019 Nov 14, 2019	BUY	$1.59 - $3.47 $46,323 - $101,094	29,134 Added 12.19%	268,086 $824,000
Q2 2019 Aug 14, 2019	BUY	$1.93 - $4.59 $365,165 - $868,450	189,205 Added 380.33%	238,952 $478,000
Q1 2019 May 15, 2019	SELL	$2.77 - $4.38 $92,947 - $146,970	-33,555 Reduced 40.28%	49,747 $214,000
Q4 2018 Feb 14, 2019	SELL	$3.03 - $5.0 $149,160 - $246,140	-49,228 Reduced 37.14%	83,302 $265,000
Q3 2018 Nov 14, 2018	BUY	$5.0 - $6.65 $662,650 - $881,324	132,530 New	132,530 $696,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.5M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Harvard Bioscience Inc Transaction History